Search results for "Cognitive deficit"

showing 10 items of 29 documents

Mobility limitations and cognitive deficits as predictors of institutionalization among community-dwelling older people.

2006

<i>Purpose:</i> Mobility limitations and cognitive disorders have often been observed as risks for institutionalization. However, their combined effects on risk of institutionalization among initially community-dwelling older people have been less well reported. <i>Design:</i> A prospective cohort study with 10-year surveillance on institutionalization. <i>Subjects:</i> Study population (n = 476) consisted of 75- and 80-year-old people who were community-dwelling, had not been diagnosed with dementia, and participated in tests on walking speed and cognitive capacity at a research centre. <i>Measures:</i> Cognitive capacity was measured with th…

GerontologyMaleAgingcognitive deficitsInstitutionalisationMEDLINERisk AssessmentlaitoshoitoDevelopmental psychologymedicineHumansProspective StudiesMobility LimitationFinlandAgedProportional Hazards ModelsAged 80 and overPsychiatric Status Rating ScalesProportional hazards modelCognitive disorderInstitutionalizationCognitionmedicine.diseaseliikkumisrajoitteetMobility Limitationmobility limitationsinstitutionalizationFemaleGeriatrics and GerontologyPsychologyOlder peopleRisk assessmentCognition Disorderskognitiiviset häiriötGerontology
researchProduct

Protective effects of mirtazapine in mice lacking the Mbnl2 gene in forebrain glutamatergic neurons: Relevance for myotonic dystrophy 1

2019

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder characterized by muscle weakness and wasting and by important central nervous system-related symptoms including impairments in executive functions, spatial abilities and increased anxiety and depression. The Mbnl2 gene has been implicated in several phenotypes consistent with DM1 neuropathology. In this study, we developed a tissue-specific knockout mouse model lacking the Mbnl2 gene in forebrain glutamatergic neurons to examine its specific contribution to the neurobiological perturbations related to DM1. We found that these mice exhibit long-term cognitive deficits and a depressive-like state associated with neuronal loss, increa…

Male0301 basic medicineMirtazapineGlutamic AcidHippocampusMice TransgenicMirtazapineMyotonic dystrophyAnimals Genetically ModifiedMice03 medical and health sciencesCellular and Molecular NeuroscienceGlutamatergicProsencephalon0302 clinical medicinemedicineAnimalsMyotonic DystrophyDentate gyrusInflammationMice KnockoutNeuronsPharmacologyDepressionbusiness.industryCognitive deficitsDentate gyrusNeurogenesisRNA-Binding Proteinsmedicine.disease3. Good healthMice Inbred C57BLNeuroprotective Agents030104 developmental biologynervous systemKnockout mouseForebrainNeuronal lossDrosophilaFemaleDM1businessNeuroscience030217 neurology & neurosurgerymedicine.drugNeuropharmacology
researchProduct

Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards

2015

Abstract Background Delirium is a neuropsychiatric disorder, triggered by medical precipitants causes. Study aims were to describe the prevalence and impact on in-hospital mortality of delirium identified through ICD-9 codes as well as evidence of neurocognitive deficits demonstrated in a population of older patients admitted to acute medical wards. Methods This was a prospective cohort multicenter study of 2521 older patients enrolled in the “Registro Politerapie SIMI (REPOSI)” during the years 2010 and 2012. The diagnosis of delirium was obtained by ICD-9 codes. Cognitive function was evaluated with the Short Blessed Test (SBT) and single SBT items were used as measures of deficits in att…

MaleHealth Knowledge Attitudes PracticePediatricsmedicine.medical_specialtySettore MED/09 - Medicina InternaActivities of daily livingMultivariate analysisUnder-detectionPopulationAcute medical wards delirium neurocognitive deficits older under-detectionSocio-culturaleLogistic regressionbehavioral disciplines and activitiesCognitionAcute medical wardRisk FactorsActivities of Daily Livingmental disordersInternal MedicinemedicineNeurocognitive deficitHumansHospital MortalityProspective StudieseducationProspective cohort studyDelirium Under-detection Neurocognitive deficits Older Acute medical wardsAgedAged 80 and overPsychiatric Status Rating Scaleseducation.field_of_studyAcute medical wardsbusiness.industryDeliriumCognitionnervous system diseasesHospitalizationneurocognitive deficitsOlderLogistic ModelsItalyMultivariate AnalysisDeliriumFemalemedicine.symptombusinessNeurocognitiveEuropean Journal of Internal Medicine
researchProduct

Jumping to conclusions, general intelligence, and psychosis liability: Findings from the multi-centre EU-GEI case-control study

2021

This study was funded by the Medical Research Council, the European Community’s Seventh Framework Program grant [agreement HEALTH-F2-2009-241909 (Project EU-GEI)], São Paulo Research Foundation (grant 2012/0417-0), the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King’s College London, the NIHR BRC at University College London and the Wellcome Trust (grant 101272/Z/12/Z).

MaleMISCOMPREHENSIONIntelligenceDELÍRIO0302 clinical medicineCognitionSCHIZOPHRENIApsychotic-like experiencejumping to conclusionsApplied PsychologyProblem SolvingRISKeducation.field_of_studyCognitionMiddle Aged16. Peace & justiceCognitive bias3. Good healthFirst episode psychosis; IQ; jumping to conclusions; polygenic risk score; psychotic-like experiences; symptom dimensionsPsychiatry and Mental healthBIASSchizophreniaRELIABILITYFemaleOriginal Articlejumping to conclusion[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]medicine.symptomClinical psychologyAdultPsychosisFirst episode psychosisAdolescentDISORDERSPopulationREEXAMINATIONDelusionssymptom dimensions03 medical and health sciencesYoung AdultPEOPLEmedicineHumansCognitive DysfunctioneducationDELUSIONAL IDEATIONCognitive deficitpsychotic-like experiencesbusiness.industryCase-control studymedicine.diseaseFirst episode psychosi030227 psychiatryPsychotic DisordersIQCase-Control StudiesJumping to conclusionspolygenic risk scorebusiness030217 neurology & neurosurgeryPsychological medicine
researchProduct

Effects of sevoflurane on cognitive deficit, motor function, and histopathology after cerebral ischemia in rats.

2009

Background: The volatile anesthetic sevoflurane exhibits neuroprotective properties when assessed for motor function and histopathology after cerebral ischemia in rats. Damage of hippocampal neurons after ischemia relates to a number of cognitive deficits that are not revealed by testing animals for motor function. Therefore, the present study evaluates cognitive and behavioral function as well as hippocampal damage in rats subjected to cerebral ischemia under sevoflurane compared with fentanyl/nitrous oxide (N 2 O)/O 2 anesthesia. Methods: Thirty-four rats were trained for 10 days using a hole-board test to detect changes in cognitive and behavioral function. Rats were randomly assigned to…

MaleMethyl EthersIschemiaNitrous OxideSevofluraneFentanylBrain IschemiaBrain ischemiaRats Sprague-DawleySevofluranemedicineAnimalsAnesthesiaCognitive deficitAnestheticsbusiness.industryBrainGeneral Medicinemedicine.diseaseImmunohistochemistryRatsFentanylAnesthesiology and Pain MedicineBlood pressureCerebral blood flowAnesthesiaData Interpretation StatisticalArterial bloodmedicine.symptomBlood Gas AnalysisbusinessCognition DisordersAnesthetics IntravenousPsychomotor Performancemedicine.drugActa anaesthesiologica Scandinavica
researchProduct

The nACHR4 594C/T polymorphism in Alzheimer disease

2006

Alzheimer disease (AD) is the most common form of dementia with complex etiology and multifactorial origin. Although several neurochemical deficits have been described in AD patients, explanation of the nature of the cognitive disturbance is focused on the "cholinergic hypothesis." The neuronal nicotinic acetylcholine receptor (neuronal nAChR) belongs to the superfamily of ionic channel activated by ligand. This paper presents a population-based population association study, testing the hypothesis that variants of the nAChR gene confer genetic susceptibility to AD. The authors analyzed two cohorts constituted by 60 controls and 80 AD patients in which significant increase of 594T polymorphi…

MaleNEURONAL NICOTINIC RECEPTORSAgingPopulationReceptors NicotinicBiologyBioinformaticsCHOLINERGIC HYPOTHESISNeurochemicalGene FrequencyAlzheimer DiseasemedicineGenetic predispositionHumansDementiaGenetic Predisposition to DiseaseBRAINeducationCognitive deficitAgedAged 80 and overGeneticseducation.field_of_studyPolymorphism GeneticMiddle Agedmedicine.diseaseGENENicotinic acetylcholine receptorCholinergicFemaleGeriatrics and Gerontologymedicine.symptomAlzheimer's disease
researchProduct

Xenon Improves Neurologic Outcome and Reduces Secondary Injury Following Trauma in an In Vivo Model of Traumatic Brain Injury*

2014

Objectives: To determine the neuroprotective efficacy of the inert gas xenon following traumatic brain injury and to determine whether application of xenon has a clinically relevant therapeutic time window. Design: Controlled animal study. Setting: University research laboratory. Subjects: Male C57BL/6N mice (n = 196). Interventions: Seventy-five percent xenon, 50% xenon, or 30% xenon, with 25% oxygen (balance nitrogen) treatment following mechanical brain lesion by controlled cortical impact. Measurements and Main Results: Outcome following trauma was measured using 1) functional neurologic outcome score, 2) histological measurement of contusion volume, and 3) analysis of locomotor functio…

MaleXenonINTRACRANIAL-PRESSURE1110 NursingCritical Care and Intensive Care MedicineGAIT ABNORMALITIESXenonGaitIntracranial pressureintegumentary systemBrainGLYCINE SITEINTRACEREBRAL-HEMORRHAGED-ASPARTATE RECEPTORNeuroprotective AgentsTreatment OutcomeAnesthesiahead traumaneuroprotectionLife Sciences & BiomedicinePOTASSIUM CHANNELSLocomotioncirculatory and respiratory physiologyinorganic chemicalsTraumatic brain injurychemistry.chemical_elementNeuroprotection1117 Public Health and Health ServicesHead traumaCritical Care MedicineIn vivoGeneral & Internal MedicineAdministration InhalationmedicineAnimalscardiovascular diseasesIntracerebral hemorrhageScience & Technologybusiness.industry1103 Clinical Sciencesbrain injurymedicine.diseaseCONTROLLED CORTICAL IMPACTCOMPETITIVE-INHIBITIONEmergency & Critical Care MedicineMice Inbred C57BLDisease Models AnimalCOGNITIVE DEFICITSchemistryBrain InjuriesClosed head injurybusinessCLOSED-HEAD INJURYinert gasesCritical Care Medicine
researchProduct

NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhag…

2007

Increased levels of glutamate and aspartate have been detected after subarachnoid hemorrhage (SAH) that correlate with neurological status. The NMDA receptor antagonist felbamate (FBM; 2-phenyl-1,3-propanediol dicarbamate) is an anti-epileptic drug that elicits neuroprotective effects in different experimental models of hypoxia-ischemia. The aim of this dose-response study was to evaluate the effect of FBM after experimental SAH in rats on (1) behavioral deficits (employing a battery of assessment tasks days 1-5 post-injury) and (2) blood-brain barrier (BBB) permeability changes (quantifying microvascular alterations according to the extravasation of protein-bound Evans Blue by a spectropho…

Malemedicine.medical_specialtyExcitotoxicityPhenylcarbamatesBehavioral deficitsmedicine.disease_causeCisterna magnaBlood–brain barrierNeuroprotectionReceptors N-Methyl-D-AspartateFelbamateRats Sprague-Dawleychemistry.chemical_compoundInternal medicinemedicineAnimalsAnimals; Blood-Brain Barrier; Rats; Subarachnoid Hemorrhage; Evans Blue; Behavioral deficits; Cognitive deficits; NMDA receptor; FelbamatePostural BalanceEvans BlueBehavior AnimalDose-Response Relationship Drugbusiness.industryCognitive deficitsMicrocirculationBody WeightGlutamate receptorSubarachnoid HemorrhageNMDA receptorFelbamateRatsEndocrinologymedicine.anatomical_structureNeuroprotective AgentsSpectrometry FluorescencechemistryBlood-Brain BarrierPropylene GlycolsAnesthesiaCerebrovascular CirculationNMDA receptorNeurology (clinical)businessmedicine.drugEvans BlueJournal of neurotrauma
researchProduct

Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure hydrocephalus

2011

Abstract Introduction It has still not been clearly established whether the cognitive deficits of idiopathic normal pressure hydrocephalus (iNPH) are caused by a disturbance in cerebrospinal fluid (CSF) dynamics or an underlying metabolic disturbance. Objective To identify the possible associations between biochemical markers, the neuroimaging characteristics, and cognitive deficits of patients undergoing investigations for possible iNPH. Methods A CSF sample obtained during a lumbar puncture from 10 patients with iNPH was analyzed for several biochemical markers (lactate, 8-isoprostane, vascular endothelial growth factor [VEGF], neurofilament heavy protein, glial fibrillary acidic protein,…

Malemedicine.medical_specialtyPathologyEpidemiologyNerve Tissue ProteinsNeuroimagingCerebral VentriclesWhite matterCellular and Molecular NeuroscienceCerebrospinal fluidDevelopmental NeuroscienceNormal pressure hydrocephalusInternal medicinemedicineHumansProspective StudiesCognitive deficitAgedAged 80 and overmedicine.diagnostic_testGlial fibrillary acidic proteinbiologyLumbar punctureHealth PolicyBrainhydrocefalusMiddle Agedmedicine.diseaseHydrocephalus Normal PressureHydrocephalusPsychiatry and Mental healthmedicine.anatomical_structurebiology.proteinCardiologyFemaleNeurology (clinical)Geriatrics and Gerontologymedicine.symptomCognition DisordersPsychologyVentriculomegalyAlzheimers & Dementia
researchProduct

Evaluation of web browsing experience by people with cognitive disability

2012

After a review of research in last 10 years we have seen the low output of work on the usability of the web, with respect to users with cognitive disabilities. This time we intend to explore the problems faced with mild or moderate intellectual disabilities when using the World Wide Web. We conducted a study to assess the Web site navigation experience using the Usability Lab of Access Research Unit, University of Valencia, where we recorded and analyzed the Web-user interaction using the technique of Thought Manifesto and Interview, from a qualitative methodological approach, to thereby detect the problems they have when surfing the Web sites for people with cognitive deficits.

ManifestoMultimediabusiness.industryApplied psychologyCognitionUsabilitycomputer.software_genreUsability labmedicineWeb navigationmedicine.symptomPsychologybusinessThink aloud protocolcomputerWeb usabilityCognitive deficitProceedings of the 13th International Conference on Interacción Persona-Ordenador - INTERACCION '12
researchProduct